| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000026845 |
| Receipt No. | R000030809 |
| Official scientific title of the study | Metabolic analysis of eosinophilic esophagitis |
| Date of disclosure of the study information | 2017/04/05 |
| Last modified on | 2017/04/03 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Metabolic analysis of eosinophilic esophagitis | |
| Title of the study (Brief title) | Metabolic analysis of eosinophilic esophagitis | |
| Region |
|
|
| Condition | ||
| Condition | Eosinophilic esophagitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate characteristic serum metabolite of eosinophilic esophagitis using metabolic analysis |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Metabolic analysis of serum taken from patients of eosinophilic esophagitis |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Eosinophilic esophagitis (EoE)
1. Patients who suffer from dysphagia and have 15 or more eosinophils/HPF in esophageal epithelium 2. Patients who provide writen informed consent 3. Patients 18 years or older Non EoE 1. Subjects without dysphagia and characteristic endoscopic findings of EoE 2. Subjects who provide writen informed consent 3. Subjects 18 years or older |
|||
| Key exclusion criteria | EoE/Non EOE
1. Sujects who have severe comorbidity 2. Subjects who have history of gastrointestinal surgery except for endoscopic treatment such as polypectomy and ESD 3. Subjects who are not eligible for participation judged by a doctor |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuhiro Fujiwara |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 1-4-3 Asahimachi, Abenoku, Osaka 545-8585 |
| TEL | 06-6645-3811 |
| yasu@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Akinari Sawada |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 1-4-3 Asahi-machi, Abeno-ku,Osaka 545- 8585, Japan |
| TEL | 06-6645-3811 |
| Homepage URL | |
| m1164972@med.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology, Osaka City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | nothing in particular |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030809 |